The National Investigation Agency (NIA) on Monday opposed the interim bail of an alleged ISIS member, after he moved a plea to undergo kidney surgery.
During a hearing in the Patiala House Court, the NIA said in its reply that if granted relief, Moinuddin Shareef Khan may hamper with the ongoing probe and flee from justice.
The agency urged the court to dismiss the application moved by Khan, who was arrested for allegedly recruiting and financing people to join the terror outfit, claiming that he was getting medical facility from Tihar jail authorities.
In its reply before the court, the NIA also stated there was no provision under the anti-terror law -- Unlawful Activities (Prevention) Act to grant interim bail to accused for medical treatment while in judicial custody.
Now court is set to hear the matter on next date of hearing, which is 8th August.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app